Synopsis

Source of validity: Traditional
Rating (out of 5): 1

Albizia species, such as Albizia lebbeck and Albizia julibrissin, have a longstanding history in traditional medicine systems, particularly in Ayurveda and Traditional Chinese Medicine, for addressing inflammatory conditions. Their use for gastrointestinal complaints, including those resembling modern classifications of inflammatory bowel disorders (IBD) like ulcerative colitis and Crohn’s disease, is primarily based on traditional practice rather than rigorous scientific validation. Ethnobotanical records indicate that Albizia bark, leaves, or flowers were sometimes employed for their anti-inflammatory, astringent, and demulcent properties, which could theoretically soothe irritated mucosa in the gut. However, there are very few clinical or preclinical studies involving Albizia species directly in the context of IBD. Some in vitro and animal research has shown that extracts may possess anti-inflammatory and antioxidant effects, but these studies rarely focus specifically on intestinal inflammation or established models of IBD. No high-quality human clinical trials have evaluated Albizia for IBD. Thus, while traditional support exists, scientific evidence remains weak and indirect, and Albizia should not be considered a validated or primary therapy for inflammatory bowel disorders.

More about Albizia (unspecified)
More about Inflammatory Bowel Disorders

Other ingredients used for Inflammatory Bowel Disorders

Other health conditions supported by Albizia (unspecified)

Products containing Albizia (unspecified)